← Back to QGEN filing summaryThis is the extracted source text from the SEC filing. Formatting may differ from the original document.
A. Operating Results MR Operating Results 43
B. Liquidity and Capital Resources MR Liquidity and Capital Resources 48
C. Research and Development, Patents and Licenses, etc. MR Research and Development 19
MR Intellectual Property, Proprietary Rights and Licenses 20
QIAGEN N.V. | Financial Report 2025 Management Report Corporate Governance Financial Statements Appendices Page 222
Reference Table Form 20-F
Item Form 20-F Caption Section Location in this Document Page
MR Research and Development 46
Item 5. D. Trend Information MR Operating Results 43
E. Critical Accounting Estimates MR Critical Accounting Estimates 53